Home › Compare › INVT vs JNJ

INVT vs JNJ: Dividend Comparison 2026

INVT yields 76066.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INVT wins by $3.148515950673885e+25M in total portfolio value
10 years
INVT
INVT
● Live price
76066.67%
Share price
$0.02
Annual div
$11.41
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.148515950673885e+25M
Annual income
$31,403,946,121,239,320,000,000,000,000,000.00
Full INVT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — INVT vs JNJ

📍 INVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINVTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INVT + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
INVT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INVT
Annual income on $10K today (after 15% tax)
$6,465,666.67/yr
After 10yr DRIP, annual income (after tax)
$26,693,354,203,053,420,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, INVT beats the other by $26,693,354,203,053,420,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INVT + JNJ for your $10,000?

INVT: 50%JNJ: 50%
100% JNJ50/50100% INVT
Portfolio after 10yr
$1.5742579753369425e+25M
Annual income
$15,701,973,060,619,660,000,000,000,000,000.00/yr
Blended yield
99.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

INVT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INVT buys
0
JNJ buys
0
No recent congressional trades found for INVT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINVTJNJ
Forward yield76066.67% ✓3.36%
Annual dividend / share$11.41 ✓$4.96
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$3.148515950673885e+25M$20.0K ✓
Annual income after 10y$31,403,946,121,239,320,000,000,000,000,000.00 ✓$827.78
Total dividends collected$3.1479834484180896e+25M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: INVT vs JNJ ($10,000, DRIP)

YearINVT PortfolioINVT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$7,617,367$7,606,666.67$10,676$355.77+$7.61M → INVT
2$5,423,362,649$5,415,212,066.46$11,407$389.39+$5423.35M → INVT
3$3,609,061,962,294$3,603,258,964,260.07$12,198$426.53+$3609061.95M → INVT
4$2,244,838,651,926,394$2,240,976,955,626,739.00$13,056$467.62+$2244838651.91M → INVT
5$1,305,101,956,254,615,300$1,302,699,978,897,054,200.00$13,987$513.12+$1305101956254.60M → INVT
6$709,211,745,327,856,400,000$707,815,286,234,663,900,000.00$14,998$563.56+$709211745327856.38M → INVT
7$360,232,984,357,827,400,000,000$359,474,127,790,326,500,000,000.00$16,098$619.52+$360232984357827392.00M → INVT
8$171,029,604,459,250,500,000,000,000$170,644,155,165,987,600,000,000,000.00$17,295$681.69+$171029604459250483200.00M → INVT
9$75,900,360,279,936,870,000,000,000,000$75,717,358,603,165,490,000,000,000,000.00$18,599$750.82+$7.590036027993687e+22M → INVT
10$31,485,159,506,738,850,000,000,000,000,000$31,403,946,121,239,320,000,000,000,000,000.00$20,022$827.78+$3.148515950673885e+25M → INVT

INVT vs JNJ: Complete Analysis 2026

INVT — Stock

Inventergy Global, Inc., an intellectual property (IP) investment and licensing company, engages in identifying, acquiring, and licensing patented technologies of various technology and small companies. The company acquires portfolios in the telecommunications industry primarily in core network infrastructure and mobile broadband communications segments. Inventergy Global, Inc. is headquartered in Campbell, California.

Full INVT Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this INVT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INVT vs SCHDINVT vs JEPIINVT vs OINVT vs KOINVT vs MAININVT vs ABBVINVT vs MRKINVT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.